Viewing Study NCT03828292


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-01-05 @ 3:44 AM
Study NCT ID: NCT03828292
Status: COMPLETED
Last Update Posted: 2025-08-19
First Post: 2019-01-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
Sponsor: GlaxoSmithKline
Organization: